Fifth Third Bancorp Insmed Inc Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
508Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$941 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$922 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$517 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.83B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...